BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29946345)

  • 21. Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
    McMillan FM; Cahoon M; White A; Hedstrom L; Petsko GA; Ringe D
    Biochemistry; 2000 Apr; 39(15):4533-42. PubMed ID: 10758003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversity of mechanisms to control bacterial GTP homeostasis by the mutually exclusive binding of adenine and guanine nucleotides to IMP dehydrogenase.
    Fernández-Justel D; Marcos-Alcalde Í; Abascal F; Vidaña N; Gómez-Puertas P; Jiménez A; Revuelta JL; Buey RM
    Protein Sci; 2022 May; 31(5):e4314. PubMed ID: 35481629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PKB/Akt interacts with inosine-5' monophosphate dehydrogenase through its pleckstrin homology domain.
    Ingley E; Hemmings BA
    FEBS Lett; 2000 Aug; 478(3):253-9. PubMed ID: 10930578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of GTP biosynthesis.
    Weber G; Nakamura H; Natsumeda Y; Szekeres T; Nagai M
    Adv Enzyme Regul; 1992; 32():57-69. PubMed ID: 1353938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
    Vethe NT; Bremer S; Bergan S
    Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of inosine 5'-monophosphate dehydrogenase as emerging new generation antimicrobial agents.
    Juvale K; Shaik A; Kirubakaran S
    Medchemcomm; 2019 Aug; 10(8):1290-1301. PubMed ID: 31534651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site.
    Prosise GL; Wu JZ; Luecke H
    J Biol Chem; 2002 Dec; 277(52):50654-9. PubMed ID: 12235158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The determination and clinical application of inosine 5’-monophosphate dehydrogenase activity].
    Liu FY; Qiu XY; Jiao Z
    Yao Xue Xue Bao; 2016 Nov; 51(11):1666-73. PubMed ID: 29908108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
    Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
    Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell activation triggers reversible inosine-5'-monophosphate dehydrogenase assembly.
    Duong-Ly KC; Kuo YM; Johnson MC; Cote JM; Kollman JM; Soboloff J; Rall GF; Andrews AJ; Peterson JR
    J Cell Sci; 2018 Sep; 131(17):. PubMed ID: 30154209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acid-base catalysis in the chemical mechanism of inosine monophosphate dehydrogenase.
    Markham GD; Bock CL; Schalk-Hihi C
    Biochemistry; 1999 Apr; 38(14):4433-40. PubMed ID: 10194364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted disruption of the inosine 5'-monophosphate dehydrogenase type I gene in mice.
    Gu JJ; Tolin AK; Jain J; Huang H; Santiago L; Mitchell BS
    Mol Cell Biol; 2003 Sep; 23(18):6702-12. PubMed ID: 12944494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inosine-5'-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells.
    Metz S; Holland S; Johnson L; Espling E; Rabaglia M; Segu V; Brockenbrough JS; Tran PO
    Endocrinology; 2001 Jan; 142(1):193-204. PubMed ID: 11145582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GTP metabolic reprogramming by IMPDH2: unlocking cancer cells' fuelling mechanism.
    Kofuji S; Sasaki AT
    J Biochem; 2020 Oct; 168(4):319-328. PubMed ID: 32702086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inosine 5'-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases.
    Ratcliffe AJ
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):595-605. PubMed ID: 17002220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
    Sintchak MD; Nimmesgern E
    Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression, purification, and characterization of inosine 5'-monophosphate dehydrogenase from Borrelia burgdorferi.
    Zhou X; Cahoon M; Rosa P; Hedstrom L
    J Biol Chem; 1997 Aug; 272(35):21977-81. PubMed ID: 9268334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mTOR-S6K1 pathway mediates cytoophidium assembly.
    Sun Z; Liu JL
    J Genet Genomics; 2019 Feb; 46(2):65-74. PubMed ID: 30857853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH.
    Kim HR; Roe JS; Lee JE; Hwang IY; Cho EJ; Youn HD
    Biochem Biophys Res Commun; 2012 Feb; 418(4):682-8. PubMed ID: 22301190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect on cell survival and cytoophidium assembly of the adRP-10-related IMPDH1 missense mutation Asp226Asn.
    Keppeke GD; Chang CC; Zhang Z; Liu JL
    Front Cell Dev Biol; 2023; 11():1234592. PubMed ID: 37731818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.